Imperative Care Appoints Ariel Sutton GM of Stroke Business

April 3, 2023—Imperative Care, Inc., a California-based medical technology company focused on developing treatments for stroke and other ischemic diseases, announced the appointment of Ariel Sutton to the newly created position of General Manager of the company’s Stroke business.

Sutton joined the company in August 2016 as EVP, Marketing, having previously held roles at Cardinal Health, Access Closure, ev3, FoxHollow Technologies, and Johnson & Johnson’s LifeScan division. A Fulbright Scholar, she graduated with an ScB in biomedical engineering from Brown University and earned an MBA at Northwestern University’s Kellogg School of Management.

“I am honored to take on this new role as Imperative Care continues to drive a patient-first approach to stroke treatment,” commented Sutton in the company's press release. “Our approach has always been to focus on the needs of the patient and to work closely with physicians to rapidly iterate our product. Our commitment to addressing urgent clinical needs in collaboration with physicians has enabled us to continually elevate patient outcomes. I am excited to have this opportunity as Imperative Care advances toward its next chapter of growth.”

Daniel Davis, Imperative Care’s President and Chief Operating Officer, added, “Under Ariel’s leadership, Imperative Care has remained focused on elevating care and bringing life-saving technologies to patients affected by stroke. Ariel’s dedication to excellence is unwavering, and I am looking forward to her leading Imperative Stroke through our next chapter as we continue to expand our clinical impact.”

Recent Imperative Care milestones include that 510(k) clearance of its first family of neurovascular access catheters in January 2019 and the April 2019 the company clearance of the Zoom aspiration system. Imperative Care's Zoom RDL stroke-specific radial access platform was cleared by the FDA for mechanical thrombectomy in January 2023.